Sv S, Augustine D, Haragannavar VC, Khudhayr EA, Matari MH, Elagi WA, Gujjar N, Patil S. Cytogenetics in oral cancer: a comprehensive update. J Contemp Dent Pract. 2022;23:123–31.

Article  PubMed  Google Scholar 

de Oliveira TB, Marta GN, de Castro JG, Kowalski LP. Induction chemotherapy for advanced oral cavity cancer. Curr Oncol Rep. 2021;23:129.

Article  PubMed  Google Scholar 

Shibahara T: [Oral cancer -diagnosis and therapy-.]. Clin Calcium. 27 1427–1433.2017

Warnakulasuriya S, Kerr AR. Oral cancer screening: past, present, and future. J Dent Res. 2021;100:1313–20.

Article  CAS  PubMed  Google Scholar 

Rodriguez-Molinero J, Miguelanez-Medran BDC, Puente-Gutierrez C, Delgado-Somolinos E, Martin Carreras-Presas C, Fernandez-Farhall J, Lopez-Sanchez AF. Association between oral cancer and diet: an update. Nutrients. 2021;13:1299.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vonk J, de Wit JG, Voskuil FJ, Witjes MJH. Improving oral cavity cancer diagnosis and treatment with fluorescence molecular imaging. Oral Dis. 2021;27:21–6.

Article  PubMed  Google Scholar 

Algudaibi LY, AlMeaigel S, AlQahtani N, Shaheen NA, Aboalela A. Oral and oropharyngeal cancer: knowledge, attitude and practices among medical and dental practitioners. Cancer Rep. 2021;4: e1349.

Article  Google Scholar 

Wang C, Liu XQ, Hou JS, Wang JN, Huang HZ. Molecular mechanisms of chemoresistance in oral cancer. Chin J Dent Res. 2016;19:25–33.

PubMed  Google Scholar 

Liu H, Wang D, Kan S, Hao M, Chang L, Lu P, Liu Y, Jin Y, Liu W. The role of lncRNAs and XIST in oral cancer. Front Cell Dev Biol. 2022;10: 826650.

Article  PubMed  PubMed Central  Google Scholar 

Zhu W, Wang J, Liu X, Xu Y, Zhai R, Zhang J, Wang M, Wang M, Liu L. lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma. Cell Death Dis. 2022;13:703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Tan J, Xu C, Wu H, Zhang Y, Xiong Y, Yi C. Identification and construction of lncRNA-associated ceRNA network in diabetic kidney disease. Medicine. 2021;100: e26062.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin X, Zhuang S, Chen X, Du J, Zhong L, Ding J, Wang L, Yi J, Hu G, Tang G, Luo X, Liu W, Ye F. lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling. Mol Ther. 2022;30:688–702.

Article  CAS  PubMed  Google Scholar 

Li J, Xu X, Zhang D, Lv H, Lei X. LncRNA LHFPL3-AS1 promotes oral squamous cell carcinoma growth and cisplatin resistance through targeting miR-362-5p/CHSY1 pathway. Onco Targets Ther. 2021;14:2293–300.

Article  PubMed  PubMed Central  Google Scholar 

Chen QF, Kong JL, Zou SC, Gao H, Wang F, Qin SM, Wang W. LncRNA LINC00342 regulated cell growth and metastasis in non-small cell lung cancer via targeting miR-203a-3p. Eur Rev Med Pharmacol Sci. 2019;23:7408–18.

PubMed  Google Scholar 

Dong YY, Zheng XW, Mijiti M, Tian R, Guo QB, Wu YY, Gao W, Wen SX. Biological function and clinical significance of long non-coding RNA LINC00342 in head and neck squamous carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023;58:240–9.

CAS  PubMed  Google Scholar 

Liu R, Yang X. LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis. BMC Cancer. 2021;21:1163.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen P, Qu L, Wang J, Ding Q, Zhou C, Xie R, Wang H, Ji G. LncRNA LINC00342 contributes to the growth and metastasis of colorectal cancer via targeting miR-19a-3p/NPEPL1 axis. Cancer Cell Int. 2021;21:105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balakittnen J, Ekanayake Weeramange C, Wallace DF, Duijf PHG, Cristino AS, Hartel G, Barrero RA, Taheri T, Kenny L, Vasani S, Batstone M, Breik O, Punyadeera C. A novel saliva-based miRNA profile to diagnose and predict oral cancer. Int J Oral Sci. 2024;16:14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chakrabortty A, Patton DJ, Smith BF, Agarwal P. miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer. Genes. 2023;14:1375.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiu L, Zheng L, Gan C, Deng W, Sun Y, Wang T. circBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression. J Oral Pathol Med. 2021;50:668–80.

Article  CAS  PubMed  Google Scholar 

Muniategui A, Pey J, Planes FJ, Rubio A. Joint analysis of miRNA and mRNA expression data. Brief Bioinform. 2013;14:263–78.

Article  CAS  PubMed  Google Scholar 

Fang R, Lu Q, Xu B. hsamiR55803p inhibits oral cancer cell viability, proliferation and migration by suppressing LAMC2. Mol Med Rep. 2021. https://doi.org/10.3892/mmr.2021.12092.

Article  PubMed  PubMed Central  Google Scholar 

Lu N, Yin Y, Yao Y, Zhang P. SNHG3/miR-2682-5p/HOXB8 promotes cell proliferation and migration in oral squamous cell carcinoma. Oral Dis. 2021;27:1161–70.

Article  PubMed  Google Scholar 

Qiu YF, Wang MX, Meng LN, Zhang R, Wang W. MiR-21 regulates proliferation and apoptosis of oral cancer cells through TNF-alpha. Eur Rev Med Pharmacol Sci. 2018;22:7735–41.

PubMed  Google Scholar 

Huang YC, Chen WC, Yu CL, Chang TK. A ICW, Chang TM, Liu JF and Wang SW: FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression. Biochem Pharmacol. 2023;218: 115853.

Article  CAS  PubMed  Google Scholar 

Wang Y, Sun Q, Ye Y, Sun X, Xie S, Zhan Y, Song J, Fan X, Zhang B, Yang M, Lv L, Hosaka K, Yang Y, Nie G. FGF-2 signaling in nasopharyngeal carcinoma modulates pericyte-macrophage crosstalk and metastasis. JCI Insight. 2022. https://doi.org/10.1172/jci.insight.157874.

Article  PubMed  PubMed Central  Google Scholar 

Chen B, Feng M, Yao Z, Zhang Z, Zhang K, Zhou L. Hypoxia promotes thyroid cancer progression through HIF1alpha/FGF11 feedback loop. Exp Cell Res. 2022;416: 113159.

Article  CAS  PubMed  Google Scholar 

Wu X, Li M, Li Y, Deng Y, Ke S, Li F, Wang Y, Zhou S. Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway. J Transl Med. 2021;19:353.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhuang Z, Jian P, Longjiang L, Bo H, Wenlin X. Oral cancer cells with different potential of lymphatic metastasis displayed distinct biologic behaviors and gene expression profiles. J Oral Pathol Med. 2010;39:168–75.

Article  PubMed  Google Scholar 

Xu RD, Feng F, Yu XS, Liu ZD, Lao LF. miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma. Int J Immunopathol Pharmacol. 2018;32:2058738418786656.

Article  PubMed  PubMed Central  Google Scholar 

Dey JH, Bianchi F, Voshol J, Bonenfant D, Oakeley EJ, Hynes NE. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis. Cancer Res. 2010;70:4151–62.

Article  CAS  PubMed  Google Scholar 

Szymczyk J, Czyrek A, Otlewski J, Zakrzewska M. FGF1 protects MCF-7 cells against taltobulin through both the MEKs/ERKs and PI3K/AKT signaling pathway. Biomedicines. 2023;11:1856.

Article  CAS  PubMed  PubMed Central